Publicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (17)

2019

  1. Statins and antiplatelet agents are associated with changes in the circulatory markers of endothelial dysfunction in chronic kidney disease

    Nefrologia, Vol. 39, Núm. 3, pp. 287-293

2018

  1. Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients

    Kidney International Reports, Vol. 3, Núm. 2, pp. 374-384

  2. Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: A propensity-score matched approach

    Nephrology Dialysis Transplantation, Vol. 33, Núm. 1, pp. 160-170

2017

  1. Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study

    American Journal of Nephrology, Vol. 46, Núm. 4, pp. 288-297

  2. The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study

    Journal of Computational Design and Engineering, Vol. 4, Núm. 3, pp. 665-675

2016

  1. Hemodialysis patients receiving a greater Kt dose than recommended have reduced mortality and hospitalization risk

    Kidney International, Vol. 90, Núm. 6, pp. 1332-1341

  2. Hyponatraemia, mortality and haemodialysis: An unexplained association

    Nefrologia, Vol. 36, Núm. 1, pp. 42-50

2015

  1. Cumulative iron dose and resistance to erythropoietin

    Journal of Nephrology, Vol. 28, Núm. 5, pp. 603-613

2014

  1. Características clínicas, analíticas y de bioimpedancia de los pacientes en hemodiálisis persistentemente hiperhidratados

    Nefrologia, Vol. 34, Núm. 6, pp. 716-723

2013

  1. Impact of targeting Kt instead of Kt/V

    Nephrology Dialysis Transplantation, Vol. 28, Núm. 10, pp. 2595-2603

2012

  1. Risk factors associated with cardiovascular morbidity and mortality in spanish incident hemodialysis patients: Two-year results from the ANSWER study

    Blood Purification, Vol. 33, Núm. 1-3, pp. 21-29

2010

  1. Mortality in incident haemodialysis patients: Time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study

    Nephrology Dialysis Transplantation, Vol. 25, Núm. 8, pp. 2702-2710

2009

  1. Baseline characteristics of an incident haemodialysis population in Spain: Results from ANSWER - A multicentre, prospective, observational cohort study

    Nephrology Dialysis Transplantation, Vol. 24, Núm. 2, pp. 578-588

  2. PHF on-line sin acetato: Cómo mejorar la hiperacetatemia y la tolerancia hemodinámica

    Nefrologia, Vol. 29, Núm. 2, pp. 156-162

2007

  1. De la osteodistrofia renal a las alteraciones del metabolismo óseo y mineral asociado a la enfermedad renal crónica: Evolución de un concepto

    Nefrologia

2006

  1. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: A cross-sectional multicentre study

    Nephrology Dialysis Transplantation, Vol. 21, Núm. 2, pp. 459-465

2004

  1. Guías de gestión de calidad del líquido de diálisis (LD)

    Nefrologia, Vol. 24, Núm. SUPPL.2, pp. 1-42